Disparities in Access to Reperfusion Therapy for Acute Ischemic Stroke (DARTS): A Comprehensive Meta-Analysis of Ethnicity, Socioeconomic Status, and Geographical Factors.

IF 7.4 2区 医学 Q1 CLINICAL NEUROLOGY
CNS drugs Pub Date : 2025-04-01 Epub Date: 2025-02-15 DOI:10.1007/s40263-025-01161-z
Raisa Biswas, Tissa Wijeratne, Kamil Zelenak, Bella B Huasen, Marta Iacobucci, Murray C Killingsworth, Roy G Beran, Mehari Gebreyohanns, Alakendu Sekhar, Dheeraj Khurana, Thanh N Nguyen, Pascal M Jabbour, Sonu M M Bhaskar
{"title":"Disparities in Access to Reperfusion Therapy for Acute Ischemic Stroke (DARTS): A Comprehensive Meta-Analysis of Ethnicity, Socioeconomic Status, and Geographical Factors.","authors":"Raisa Biswas, Tissa Wijeratne, Kamil Zelenak, Bella B Huasen, Marta Iacobucci, Murray C Killingsworth, Roy G Beran, Mehari Gebreyohanns, Alakendu Sekhar, Dheeraj Khurana, Thanh N Nguyen, Pascal M Jabbour, Sonu M M Bhaskar","doi":"10.1007/s40263-025-01161-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Reperfusion therapies, such as intravenous thrombolysis (IVT) and endovascular thrombectomy (EVT), are crucial for improving outcomes in patients with acute ischemic stroke (AIS). However, access to these treatments can vary significantly due to ethnicity, socioeconomic status (SES), and geographical location, impacting patient outcomes.</p><p><strong>Objectives: </strong>The Disparities in Access to Reperfusion Therapy for Acute Ischemic Stroke (DARTS) study aims to systematically assess disparities in access to IVT and EVT on the basis of ethnicity, SES, and geographical location.</p><p><strong>Methods: </strong>A comprehensive meta-analysis was conducted, incorporating data from 38 studies involving 5,256,531 patients with AIS. The analysis evaluated IVT and EVT utilization rates across ethnic groups, SES levels, and geographical locations.</p><p><strong>Results: </strong>The findings reveal substantial disparities in access to reperfusion therapies. IVT and EVT utilization rates varied significantly by ethnicity (9% ethnic, 11% non-ethnic for IVT; 7% ethnic, 6% non-ethnic for EVT), SES (13% low SES, 16% high SES for IVT; 7% low SES, 10% high SES for EVT), and geography (9% rural, 12% urban for IVT; 1% rural, 4% urban for EVT). Black patients had significantly lower odds of receiving IVT (OR 0.69, p = 0.001) and EVT (OR 0.87, p = 0.005) compared with white patients. Similarly, patients with low SES and those from rural areas faced reduced odds of receiving IVT (OR 0.74, p < 0.001; OR 0.72, p = 0.002) and EVT (OR 0.74, p < 0.001; OR 0.39, p < 0.001). Rural patients also had significantly lower odds of timely hospital arrival (p < 0.001), posing a barrier to accessing reperfusion therapies.</p><p><strong>Conclusions: </strong>The DARTS study (and this meta-analysis) reveals significant access disparities in AIS treatment related to ethnicity, geography, and SES, particularly affecting Black communities, low SES individuals, and rural populations. Despite advances in reperfusion therapies, suboptimal implementation rates persist. To address these issues, we recommend the EQUITY framework: Educate, Ensure Quality, provide Universal Access, Implement Inclusive Policy Reforms, Enhance Timely Data Collection, and Yield Culturally Sensitive Care Practices. Adopting these recommendations will improve access, reduce disparities, and enhance stroke management and outcomes globally. Equitable access is essential for all eligible patients to fully benefit from reperfusion treatments.</p>","PeriodicalId":10508,"journal":{"name":"CNS drugs","volume":" ","pages":"417-442"},"PeriodicalIF":7.4000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CNS drugs","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s40263-025-01161-z","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/15 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Reperfusion therapies, such as intravenous thrombolysis (IVT) and endovascular thrombectomy (EVT), are crucial for improving outcomes in patients with acute ischemic stroke (AIS). However, access to these treatments can vary significantly due to ethnicity, socioeconomic status (SES), and geographical location, impacting patient outcomes.

Objectives: The Disparities in Access to Reperfusion Therapy for Acute Ischemic Stroke (DARTS) study aims to systematically assess disparities in access to IVT and EVT on the basis of ethnicity, SES, and geographical location.

Methods: A comprehensive meta-analysis was conducted, incorporating data from 38 studies involving 5,256,531 patients with AIS. The analysis evaluated IVT and EVT utilization rates across ethnic groups, SES levels, and geographical locations.

Results: The findings reveal substantial disparities in access to reperfusion therapies. IVT and EVT utilization rates varied significantly by ethnicity (9% ethnic, 11% non-ethnic for IVT; 7% ethnic, 6% non-ethnic for EVT), SES (13% low SES, 16% high SES for IVT; 7% low SES, 10% high SES for EVT), and geography (9% rural, 12% urban for IVT; 1% rural, 4% urban for EVT). Black patients had significantly lower odds of receiving IVT (OR 0.69, p = 0.001) and EVT (OR 0.87, p = 0.005) compared with white patients. Similarly, patients with low SES and those from rural areas faced reduced odds of receiving IVT (OR 0.74, p < 0.001; OR 0.72, p = 0.002) and EVT (OR 0.74, p < 0.001; OR 0.39, p < 0.001). Rural patients also had significantly lower odds of timely hospital arrival (p < 0.001), posing a barrier to accessing reperfusion therapies.

Conclusions: The DARTS study (and this meta-analysis) reveals significant access disparities in AIS treatment related to ethnicity, geography, and SES, particularly affecting Black communities, low SES individuals, and rural populations. Despite advances in reperfusion therapies, suboptimal implementation rates persist. To address these issues, we recommend the EQUITY framework: Educate, Ensure Quality, provide Universal Access, Implement Inclusive Policy Reforms, Enhance Timely Data Collection, and Yield Culturally Sensitive Care Practices. Adopting these recommendations will improve access, reduce disparities, and enhance stroke management and outcomes globally. Equitable access is essential for all eligible patients to fully benefit from reperfusion treatments.

急性缺血性卒中再灌注治疗的可及性差异(DARTS):种族、社会经济地位和地理因素的综合meta分析。
背景:静脉溶栓(IVT)和血管内取栓(EVT)等再灌注治疗对于改善急性缺血性卒中(AIS)患者的预后至关重要。然而,由于种族、社会经济地位(SES)和地理位置的不同,获得这些治疗的机会可能会有很大差异,从而影响患者的预后。目的:急性缺血性卒中再灌注治疗的可及性差异(DARTS)研究旨在系统评估基于种族、社会经济地位和地理位置的IVT和EVT可及性差异。方法:进行了一项综合荟萃分析,纳入了38项研究的数据,涉及5256531例AIS患者。该分析评估了不同种族、社会经济地位和地理位置的IVT和EVT使用率。结果:研究结果揭示了获得再灌注治疗的实质性差异。IVT和EVT使用率因种族而有显著差异(IVT中族裔占9%,非族裔占11%;EVT为7%族裔,6%非族裔),SES (IVT为13%低SES, 16%高SES;EVT为7%的低SES, 10%的高SES),和地理(IVT为9%的农村,12%的城市;农村占1%,城市占4%)。与白人患者相比,黑人患者接受IVT (OR 0.69, p = 0.001)和EVT (OR 0.87, p = 0.005)的几率显著降低。同样,社会经济地位低的患者和来自农村地区的患者接受IVT的几率降低(OR 0.74, p < 0.001;OR 0.72, p = 0.002)和EVT (OR 0.74, p < 0.001;OR 0.39, p < 0.001)。农村患者及时到达医院的几率也明显较低(p < 0.001),这对获得再灌注治疗构成了障碍。结论:DARTS研究(和本荟萃分析)揭示了与种族、地理和社会经济地位有关的AIS治疗的显著可及性差异,特别是影响黑人社区、低社会经济地位个体和农村人口。尽管再灌注治疗取得了进展,但执行率仍然不理想。为解决这些问题,我们建议采用以下公平框架:教育、确保质量、提供普遍可及性、实施包容性政策改革、加强及时数据收集和产生具有文化敏感性的护理做法。采纳这些建议将改善可及性,缩小差距,并在全球范围内加强脑卒中管理和结果。公平获取对所有符合条件的患者充分受益于再灌注治疗至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CNS drugs
CNS drugs 医学-精神病学
CiteScore
12.00
自引率
3.30%
发文量
82
审稿时长
6-12 weeks
期刊介绍: CNS Drugs promotes rational pharmacotherapy within the disciplines of clinical psychiatry and neurology. The Journal includes: - Overviews of contentious or emerging issues. - Comprehensive narrative reviews that provide an authoritative source of information on pharmacological approaches to managing neurological and psychiatric illnesses. - Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement. - Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in neurology and psychiatry. - Original research articles reporting the results of well-designed studies with a strong link to clinical practice, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials, meta-analyses, outcomes research, and pharmacoeconomic and pharmacoepidemiological studies. Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in CNS Drugs may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信